Bright Minds Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bright Minds Biosciences generated cash of -$7,024,265, which is more than the previous year. Cash used in financing activities reached the amount of $2,189,686 last year. Net change in cash is therefore -$4,879,927.
Cash Flow
| 2019 | -42.00K | 0 | 122K |
|---|---|---|---|
| 2020 | -288.39K | 0 | 1.00M |
| 2021 | -7.31M | 0 | 26.05M |
| 2022 | -13.58M | 0 | 5.19M |
| 2023 | -7.02M | 0 | 2.18M |
DRUG Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 11.62M | 19.76M | 799.92K | 79.99K | 0 |
Operating activities | |||||
Net income | -7.37M | -14.96M | -8.65M | -480.37K | -78.71K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 72.45K | 6.03K | 0 | 0 | 0 |
Stock-based compensation expense | 1.15M | 875.05K | 880.61K | 161.3K | 0 |
| Deferred income tax benefit | 1.15M | 875.05K | 880.61K | 161.3K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | -45.63K | -110.14K | 0 | 0 |
Inventories | 0 | 0 | 110.14K | 0 | 0 |
Accounts payable | 0 | 0 | 506.15B | 0 | 0 |
Cash generated by operating activities | -7.02M | -13.58M | -7.31M | -288.39K | -42.00K |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 5 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 1.21M | 4.03M | 27.74M | 1.00M | 122K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -86.11K | -7.16K | 0 | 0 | 0 |
Cash used in financing activities | 2.18M | 5.19M | 26.05M | 1.00M | 122K |
Net Change In Cash | -4.87M | -8.13M | 18.96M | 719.93K | 79.99K |
Cash at end of period | 6.74M | 11.62M | 19.76M | 799.92K | 79.99K |
| Data source | Data source |